Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Medical Center Groningen
About this trial
The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with a (supra)sellar tumor
Visual field loss based on the most recent SAP; False positive rate <15%; fixation losses <20%
Informed written consent
Disqualifiers
Neurological disorders
Eye disease not related to a (supra)sellar tumor
Trial population
Patients with a (supra)sellar tumour and healthy controls
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
SONDA
Diagnostic testPerimetry based visualfield analysis
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Patients1 intervention
Group B: Healthy controls1 intervention
Trial outcomes
Primary outcomes
1
Convert validity
Difference (dB) between the predicted MD (SONDA) and the assessed MD (SAP), expressed as delta MD.
Time frame
Baseline2
Test-retest reliability
The variability of the predicted MD (dB) between consecutive measurements in the same person.
Time frame
baseline 1, baseline 2, 6-8 weeks post-operativeSecondary outcomes
1
Experience
The experience of patients expressed in scores and descriptives based on a questionnaire: Questionnaire Standardized Oculomotor and Neuro-Ophthalmic Disorder Assessment
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: